Prof Timila Yami ThapaShe is an educator, policy planner, and pioneer in engineering and technology …
Read More »Osimertinib Plus Chemotherapy for Advanced EGFR-Mutated Lung Cancer
The recent FDA approval of a groundbreaking therapy with Osimertinib has transformed the landscape of non-small cell lung cancer (NSCLC) treatment. Osimertinib, known by its brand name Tagrisso, in combination with chemotherapy, has received the regulatory nod for the treatment of locally advanced or metastatic Epidermal Growth Factor Receptor EGFR-mutated …
Read More »
Medicosnext













